Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
5
Neutral
5
Bullish
4
Bearish
8
Neutral
5
Bullish
33
Bearish
3
Neutral
0
Bullish
29
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Star Health & Allied Insurance Company Ltd (STARHEALTH) is currently trading at 465.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Star Health and Allied Insurance Ltd is a leading health insurance provider in India, offering a range of health, personal accident, and travel insurance products through a vast agent and partner network. The company reported a strong financial performance with a 16% increase in Gross Written Premium (GWP) for 9M FY2026, reaching Rs. 13,856 crore. This was supported by a significant PAT increase of 87% to Rs. 966 crore. Digital and agency channels were pivotal to growth, with the digital channel seeing a GWP increase of 35% year-on-year for nine months, demonstrating a shift towards digital-first strategies. Star Health benefits from policy tailwinds such as the GST exemption on retail health insurance, enhancing affordability and demand, thereby supporting its leadership in the market. Improvements in claims ratios and operational efficiencies, such as a 222-basis-point improvement in the combined ratio, reflect the company's ongoing focus on cost management and service optimization.
Over the past 52 weeks, Star Health & Allied Insurance Company Ltd has traded between a low of ₹330.05 and a high of ₹533.90. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Star Health & Allied Insurance Company Ltd has a market capitalization of approximately 27,581.41. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Star Health & Allied Insurance Company Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 61.83 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 27,581.41 Cr, Star Health & Allied Insurance Company Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Star Health & Allied Insurance Company Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Star Health & Allied Insurance Company Ltd is 61.83. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The most significant impact is the 11% increase in the national healthcare budget to ₹99,859 crores. This expanded government spending is expected to boost health awareness and drive higher demand for retail health insurance, directly benefiting market leaders like Star Health.
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q4 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Upcoming Result Date: Apr 27, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Star Health and Allied Insurance Ltd is a leading health insurance provider in India, offering a range of health, personal accident, and travel insurance products through a vast agent and partner network.
The company reported a strong financial performance with a 16% increase in Gross Written Premium (GWP) for 9M FY2026, reaching Rs. 13,856 crore. This was supported by a significant PAT increase of 87% to Rs. 966 crore.
Digital and agency channels were pivotal to growth, with the digital channel seeing a GWP increase of 35% year-on-year for nine months, demonstrating a shift towards digital-first strategies.
Star Health benefits from policy tailwinds such as the GST exemption on retail health insurance, enhancing affordability and demand, thereby supporting its leadership in the market.
Improvements in claims ratios and operational efficiencies, such as a 222-basis-point improvement in the combined ratio, reflect the company's ongoing focus on cost management and service optimization.
Insurance
General Insurance
27,581 Cr
Low Risk
61.8
15.4
1.3
3.7
533.90
330.05
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1470.70 | 50,578 Cr | 356.10 | 9.54 | 0.00 | 3.04 | 3.53 | 0.09 | ||
320.45 | 29,690 Cr | 58.21 | 6.41 | 0.00 | 10.55 | 10.50 | 2.19 | ||
465.25 | 27,581 Cr | 61.83 | 3.70 | 0.00 | 7.16 | 8.87 | 2.10 | ||
123.10 | 20,287 Cr | 16.98 | 0.70 | 1.46 | 4.03 | 2.35 | 1.00 | ||
144.60 | 13,732 Cr | 117.56 | 8.74 | 0.28 | 7.89 | 0.29 | 0.26 | ||
72.56 | 13,405 Cr | -449.92 | 3.52 | 0.00 | 2.43 | 2.28 | -0.08 | ||
319.20 | 2,398 Cr | 42.87 | 3.08 | 0.00 | 14.05 | 13.35 | 3.97 | ||
| Median: 7 Co. | — | 319.20 | 20,287 Cr | 58.21 | 3.70 | 0.00 | 7.16 | 3.53 | 1.00 |
Credit Rating
CARE Ratings has reaffirmed Star Health & Allied Insurance's issuer rating at AA+ (Stable) and its subordinate debt rating at AA (Stable), disclosed under SEBI LODR Regulations 30 and 55.
Credit Rating
CARE Ratings has reaffirmed Star Health's issuer rating at AA+ (Stable) and subordinate debt rating at AA (Stable) — disclosed under Reg. 30/55 on Apr 2, 2026.
Board Meeting Intimation
Star Health & Allied Insurance schedules a Board meeting on April 28, 2026 to consider and approve the standalone audited financial results for the year ended March 31, 2026.
Board Meeting Intimation
Star Health & Allied Insurance informed exchanges that its Board will meet on April 28, 2026 to consider and approve the standalone audited financial results for the year ended March 31, 2026.
